Experimental drug trial aims to save children from Life-Threatening shock
Disease control
ENROLLING_BY_INVITATION
This study is testing whether adding the drug Angiotensin II (brand name Giapreza) to standard treatments can help stabilize dangerously low blood pressure in critically ill children. Researchers will enroll 30 pediatric patients whose blood pressure remains dangerously low despi…
Phase: PHASE4 • Sponsor: Todd Sweberg • Aim: Disease control
Last updated Mar 20, 2026 14:48 UTC